BioWorld

Feb. 7, 2000

View Archived Issues

NeoRx Moves Skeletal Targeted Radiotherapy To Phase III Study

Read More

Genzyme Transgenics Raises $70M In Public Stock Offering

Read More

Other News To Note

Read More

Agouron, PPD In $30M Pact To Find Targets Against HIV

Read More

Lab Rats Treated With Switched Amino Acid Peptide Overcame Prostate Cancer Lung Metastasis

Read More

Biotech Could Be Affected By FASB Interest-Pooling Hearings

Read More

COR's Integrilin Succeeds In Coronary Intervention Study

Read More

Rigel Continues Run Of Filings As It Seeks $100M Through IPO

Read More

Antigenics' IPO Raises $63M To Fund Trials Of Oncophage

Read More